tiprankstipranks
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
US Market

Eterna Therapeutics (ERNA) Income Statement

Compare
258 Followers

Eterna Therapeutics Income Statement

Last quarter (Q3 2024), Eterna Therapeutics's total revenue was $487.00K, an increase of 854.90% from the same quarter last year. In Q3, Eterna Therapeutics's net income was $-26.60M. See Eterna Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 68.00K$ 0.00$ 0.00$ 0.00$ 19.81M
Gross Profit
$ -168.00K$ -497.00K$ -459.00K$ -98.00K$ 11.96M
Operating Expenses
$ 20.97M$ 27.23M$ 27.43M$ 7.25M$ 13.18M
Depreciation and Amortization
$ 1.12M$ 497.00K$ 459.00K$ 98.00K$ 3.17M
EBITDA
$ -19.93M$ -33.22M$ -121.95M$ -7.15M$ 1.96M
Operating Income
$ -21.14M$ -33.22M$ 68.34M$ -7.25M$ -1.21M
Other Income/Expenses
$ -536.00K$ 8.68M$ -95.05M$ -19.28M$ -808.00K
Pretax Income
$ -21.67M$ -24.53M$ -122.30M$ -7.29M$ -2.02M
Net Income
$ -21.67M$ -24.58M$ -122.31M$ 11.91M$ -2.05M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -4.08$ -8.06$ -56.49$ 27.08$ -28.48
Diluted EPS
$ -4.08$ -8.06$ -56.49$ 27.08$ -28.48
Weighted Average Shares Outstanding
5.31M 3.05M 2.17M 439.70K 71.88K
Weighted Average Shares Outstanding (Diluted)
5.31M 3.05M 2.17M 439.70K 71.88K
Currency in USD

Eterna Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis